PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+10.89%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$632M
AUM Growth
+$187M
(+42%)
Cap. Flow
+$70.5M
Cap. Flow
% of AUM
11.16%
Top 10 Holdings %
Top 10 Hldgs %
20.26%
Holding
1,889
New
702
Increased
297
Reduced
216
Closed
332
Top Buys
| 1 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
$24.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
$8.38M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
$7.02M |
| 4 |
Broadcom
AVGO
|
$5.75M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$4.67M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$16.1M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
$11.4M |
| 3 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$11.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$10.3M |
| 5 |
Micron Technology
MU
|
$9.51M |
Sector Composition
| 1 | Technology | 20.09% |
| 2 | Consumer Discretionary | 14.44% |
| 3 | Healthcare | 9.84% |
| 4 | Financials | 8.51% |
| 5 | Industrials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
251
DELISTED
Chimerix, Inc.
CMRX
| $572K | 0.03% |
+184,657
| New | +$572K |
|
|
ICAD
252
DELISTED
iCAD Inc
ICAD
| $565K | 0.03% |
56,563
+14,049
| +33% | +$140K |
|
253
Huntsman Corp
HUN
$1.95B
| $564K | 0.03% |
+31,389
| New | +$564K |
|
254
Idexx Laboratories
IDXX
$51.4B
| $564K | 0.03% |
+1,709
| New | +$564K |
|
255
Northern Trust
NTRS
$24.3B
| $562K | 0.03% |
+7,080
| New | +$562K |
|
256
Zai Lab
ZLAB
$3.42B
| $558K | 0.03% |
+6,800
| New | +$558K |
|
257
Raymond James Financial
RJF
$33B
| $556K | 0.03% |
+12,120
| New | +$556K |
|
258
Charter Communications
CHTR
$35.7B
| $553K | 0.03% |
+1,085
| New | +$553K |
|
259
iShares Silver Trust
SLV
$20.1B
| $552K | 0.03% |
32,445
+10,792
| +50% | +$184K |
|
260
Exelon
EXC
$43.9B
| $549K | 0.03% |
+21,191
| New | +$549K |
|
261
Pinterest
PINS
$25.8B
| $547K | 0.03% |
+24,680
| New | +$547K |
|
262
Western Union
WU
$2.86B
| $547K | 0.03% |
25,316
+23,458
| +1,263% | +$507K |
|
|
MNTA
263
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $537K | 0.03% |
16,144
+8,791
| +120% | +$292K |
|
264
DexCom
DXCM
$31.6B
| $531K | 0.03% |
+5,244
| New | +$531K |
|
265
Fate Therapeutics
FATE
$116M
| $530K | 0.03% |
+15,448
| New | +$530K |
|
266
Cardinal Health
CAH
$35.7B
| $526K | 0.03% |
10,083
+7,851
| +352% | +$410K |
|
267
Purple Innovation
PRPL
$122M
| $525K | 0.03% |
29,148
+28,648
| +5,730% | +$516K |
|
268
SandRidge Energy
SD
$420M
| $523K | 0.03% |
405,550
+4,537
| +1% | +$5.85K |
|
269
LiveRamp
RAMP
$1.86B
| $516K | 0.03% |
+12,140
| New | +$516K |
|
270
BioMarin Pharmaceuticals
BMRN
$11.1B
| $515K | 0.03% |
4,177
+1,209
| +41% | +$149K |
|
271
Berkshire Hathaway Class B
BRK.B
$1.08T
| $515K | 0.03% |
2,884
+876
| +44% | +$156K |
|
272
Trane Technologies
TT
$92.1B
| $515K | 0.03% |
+5,786
| New | +$515K |
|
273
Eastman Chemical
EMN
$7.93B
| $508K | 0.03% |
+7,297
| New | +$508K |
|
274
Prologis
PLD
$105B
| $507K | 0.03% |
5,429
+5,155
| +1,881% | +$481K |
|
275
United Therapeutics
UTHR
$18.1B
| $506K | 0.03% |
+4,180
| New | +$506K |
|